Worth reading
59In focus
Scored from 5 of 6 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
450
¥ hundred millionWording
Conditional
How definitive the wording is.Results for this period
Third quarter2023年1月1日〜2023年9月30日ConsolidatedIFRSNet Sales2,157,018¥ millionYear on year +7.4%Progress 75.8%
Operating profit631,847¥ millionYear on year +9.1%Progress 93.2%
Ordinary income586,209¥ millionYear on year +9.4%
Net income attributable to owners of the parent442,010¥ millionYear on year +9.5%Progress 95.3%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share249.01円
Financial position at period-end
Total assets7,101,511¥ million
of which net assets 4,001,649 ¥ millionEquity ratio 55.2%vs. prior year-end +1.1pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+490,434
Investment-104,040
Financials-413,746
Net change-27,352
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥869,042 million
Segment revenueTobacco business Current fiscal year ¥1,974,535 million / Prior-year period ¥1,834,539 million / Year on year against the same period last year Not disclosed / Pharmaceuticals Current fiscal year ¥69,799 million / Prior-year period ¥59,665 million / Year on year against the same period last year Not disclosed / Processed Food Operations Current fiscal year ¥111,486 million / Prior-year period ¥112,798 million / Year on year against the same period last year Not disclosed
Segment profitTobacco business Current fiscal year ¥676,831 million / Prior-year period ¥653,450 million / Year on year against the same period last year Not disclosed / Pharmaceuticals Current fiscal year ¥13,118 million / Prior-year period ¥7,267 million / Year on year against the same period last year Not disclosed / Processed Food Operations Current fiscal year ¥4,648 million / Prior-year period ¥1,858 million / Year on year against the same period last year Not disclosed
Regional salesAsia Current fiscal year ¥599,069 million / Prior-year period ¥609,306 million / Year on year against the same period last year Not disclosed / Western Europe Current fiscal year ¥467,596 million / Prior-year period ¥413,417 million / Year on year against the same period last year Not disclosed / EMA Current fiscal year ¥824,614 million / Prior-year period ¥737,945 million / Year on year against the same period last year Not disclosed
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥2,844,000 million (YoY +7.0%)
Operating profit¥678,000 million (YoY +3.7%)
Ordinary incomeNot disclosed
Net income¥464,000 million (YoY +4.8%)
Revision to Earnings ForecastRevenue ¥27,590 hundred million → ¥28,440 hundred million（+3.1%） / Adjusted operating profit ¥6,830 hundred million → ¥7,210 hundred million（+5.6%） / Operating profit ¥6,330 hundred million → ¥6,780 hundred million（+7.1%） / Profit for the period (attributable to owners of the parent) ¥4,570 hundred million → ¥4,640 hundred million（+1.5%） / 為替一定ベース調整後営業利益 ¥7,300 hundred million → ¥7,640 hundred million（+4.7%）
Annual Dividend Forecast¥188 → ¥188（0.0%）
Factors Behind Changes in Business Performance
足元までの状況等を織り込んだこと。たばこ製造機械の見積耐用年数を10〜15年から18年へ見直したことにより、営業利益が6,623百万円増加。
Disclosure regarding the going concern assumption
No applicable matters.
Change in accounting policy
基準改正に伴う変更 Yesそれ以外の変更 No見積りの変更 Yes修正再表示 No
Changes in the scope of consolidationNew 0 / Excluded 1 / Companies excluded from consolidation JT INTERNATIONAL GROUP HOLDING B.V.
Impairment loss¥6,441 million
Depreciation and amortization¥130,241 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable Yes / Subject person Analysts and institutional investors
Issued Shares at Period-End2,000,000,000
Treasury Shares at Period-End224,694,743
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2023年1月1日〜2023年9月30日 |
| Net Sales | ¥2,157,018 million (YoY +7.4%) |
| Operating profit | ¥631,847 million (YoY +9.1%) |
| Ordinary income | ¥586,209 million (YoY +9.4%) |
| Profit attributable to owners of the parent | ¥442,010 million (YoY +9.5%) |
| Net income per share | 249.01円 |
| Equity ratio | End of the current fiscal period 55.2 / End of previous period 54.1 |
| Total assets | ¥7,101,511 million |
| Net assets | ¥4,001,649 million |
| Cash flows from operating activities | ¥490,434 million |
| Cash flows from investing activities | ¥-104,040 million |
| Cash flows from financing activities | ¥-413,746 million |
| Cash and cash equivalents at end of period | ¥869,042 million |
| Full-year earnings forecast | Net Sales ¥2,844,000 million (YoY +7.0%) / Operating profit ¥678,000 million (YoY +3.7%) / Ordinary income Not disclosed / Net income ¥464,000 million (YoY +4.8%) |
| Revision to Earnings Forecast | Revenue ¥27,590 hundred million → ¥28,440 hundred million（+3.1%） / Adjusted operating profit ¥6,830 hundred million → ¥7,210 hundred million（+5.6%） / Operating profit ¥6,330 hundred million → ¥6,780 hundred million（+7.1%） / Profit for the period (attributable to owners of the parent) ¥4,570 hundred million → ¥4,640 hundred million（+1.5%） / 為替一定ベース調整後営業利益 ¥7,300 hundred million → ¥7,640 hundred million（+4.7%） |
| Annual Dividend Forecast | ¥188 → ¥188（0.0%） |
| Segment revenue | Tobacco business Current fiscal year ¥1,974,535 million / Prior-year period ¥1,834,539 million / Year on year against the same period last year Not disclosed / Pharmaceuticals Current fiscal year ¥69,799 million / Prior-year period ¥59,665 million / Year on year against the same period last year Not disclosed / Processed Food Operations Current fiscal year ¥111,486 million / Prior-year period ¥112,798 million / Year on year against the same period last year Not disclosed |
| Segment profit | Tobacco business Current fiscal year ¥676,831 million / Prior-year period ¥653,450 million / Year on year against the same period last year Not disclosed / Pharmaceuticals Current fiscal year ¥13,118 million / Prior-year period ¥7,267 million / Year on year against the same period last year Not disclosed / Processed Food Operations Current fiscal year ¥4,648 million / Prior-year period ¥1,858 million / Year on year against the same period last year Not disclosed |
| Regional sales | Asia Current fiscal year ¥599,069 million / Prior-year period ¥609,306 million / Year on year against the same period last year Not disclosed / Western Europe Current fiscal year ¥467,596 million / Prior-year period ¥413,417 million / Year on year against the same period last year Not disclosed / EMA Current fiscal year ¥824,614 million / Prior-year period ¥737,945 million / Year on year against the same period last year Not disclosed |
| Depreciation and amortization | ¥130,241 million |
| Impairment loss | ¥6,441 million |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards Yes / Other changes No / Change in accounting estimate Yes / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 1 / Companies excluded from consolidation JT INTERNATIONAL GROUP HOLDING B.V. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Analysts and institutional investors |
| Issued Shares at Period-End | 2,000,000,000 |
| Treasury Shares at Period-End | 224,694,743 |
| Factors Behind Changes in Business Performance | 足元までの状況等を織り込んだこと。たばこ製造機械の見積耐用年数を10〜15年から18年へ見直したことにより、営業利益が6,623百万円増加。 |
Items this document does not state (6)
Operating MarginPayout ratioShareholder Return PolicyOrders received and order backlogBreakdown of extraordinary income (loss)Material subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.足元までの状況等を業績予想に織り込んだこと。加えて、たばこ製造機械の見積耐用年数を18年へ見直した会計上の見積り変更により、当第3四半期連結累計期間の営業利益は6,623百万円増加した。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.